STOCK TITAN

[Form 4] Centene Corporation Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Centene Corporation director and chief executive officer Sarah London reported an open-market purchase of common stock on 08/08/2025. The filing shows acquisition of 19,230 shares at a weighted average price of $25.49–$25.50, increasing her reported direct beneficial ownership to 845,275 shares. The ownership total explicitly includes 591,998 shares represented by previously-granted restricted stock units and performance stock units reported at target levels and subject to vesting.

The report also discloses 13,449 performance-style stock options with an exercise price of $81.85, tied to a grant with a performance condition that the common stock close at or above $100 for 20 consecutive trading days before they may become exercisable. The form was executed by an attorney-in-fact.

Sarah London, direttore e amministratore delegato di Centene Corporation ha dichiarato un acquisto in mercato aperto di azioni ordinarie il 08/08/2025. Il deposito mostra l'acquisizione di 19.230 azioni a un prezzo medio ponderato di $25,49–$25,50, portando la sua partecipazione diretta dichiarata a 845.275 azioni. Il totale di proprietà include esplicitamente 591.998 azioni rappresentate da unità azionarie vincolate (RSU) e unità azionarie a prestazione (PSU) precedentemente assegnate, riportate al livello target e soggette a vesting.

La segnalazione rivela inoltre 13.449 opzioni azionarie di tipo performance con prezzo di esercizio di $81,85, legate a una concessione con condizione di performance secondo cui le azioni ordinarie devono chiudere a o sopra $100 per 20 giorni di negoziazione consecutivi prima che possano diventare esercitabili. Il modulo è stato firmato da un procuratore.

Sarah London, directora y consejera delegada de Centene Corporation, informó una compra en mercado abierto de acciones ordinarias el 08/08/2025. La presentación muestra la adquisición de 19.230 acciones a un precio medio ponderado de $25,49–$25,50, aumentando su propiedad directa declarada a 845.275 acciones. El total de propiedad incluye explícitamente 591.998 acciones representadas por unidades restringidas (RSU) y unidades de acciones por desempeño (PSU) previamente otorgadas, reportadas al nivel objetivo y sujetas a adquisición.

El informe también divulga 13.449 opciones de acciones de estilo rendimiento con un precio de ejercicio de $81,85, vinculadas a una concesión con la condición de rendimiento de que las acciones ordinarias cierren en o por encima de $100 durante 20 días de negociación consecutivos antes de que puedan hacerse ejercitables. El formulario fue firmado por un apoderado.

Centene Corporation 이사 겸 최고경영자(CEO) Sarah London은 2025년 8월 8일 공개 시장에서 보통주를 매수했다고 보고했습니다. 신고서에 따르면 가중평균 가격 $25.49–$25.5019,230주를 취득해 그녀의 신고된 직접 실질 보유주식이 845,275주로 증가했습니다. 소유 총액에는 이전에 부여된 제한부주식단위(RSU) 및 성과기반주식단위(PSU)로 보고된, 베스팅 대상의 591,998주가 명시적으로 포함되어 있습니다.

보고서에는 또한 행사 가격이 $81.8513,449개의 성과형 스톡옵션이 공개되어 있는데, 이는 보통주가 연속 20거래일 동안 $100 이상으로 종가를 기록해야만 행사 가능해지는 성과 조건이 붙은 부여와 연계되어 있습니다. 서식은 위임대리인이 서명했습니다.

Sarah London, administratrice et directrice générale de Centene Corporation, a déclaré un achat en marché ouvert d'actions ordinaires le 08/08/2025. Le dépôt indique l'acquisition de 19 230 actions à un prix moyen pondéré de 25,49 $–25,50 $, portant sa participation directe déclarée à 845 275 actions. Le total de propriété inclut explicitement 591 998 actions représentées par des unités d'actions restreintes (RSU) et des unités d'actions à performance (PSU) précédemment attribuées, déclarées au niveau cible et soumises au vesting.

Le rapport divulgue également 13 449 options d'actions de type performance avec un prix d'exercice de 81,85 $, liées à une attribution soumise à la condition de performance selon laquelle les actions ordinaires doivent clôturer à ou au-dessus de 100 $ pendant 20 jours de négociation consécutifs avant de pouvoir être exerçables. Le formulaire a été signé par un mandataire.

Sarah London, Direktorin und Chief Executive Officer von Centene Corporation, meldete am 08.08.2025 einen Kauf von Stammaktien am freien Markt. Die Meldung weist den Erwerb von 19.230 Aktien zu einem gewichteten Durchschnittspreis von $25,49–$25,50 aus und erhöhte ihr gemeldetes direktes wirtschaftliches Eigentum auf 845.275 Aktien. Die Gesamtbeteiligung schließt ausdrücklich 591.998 Aktien ein, die durch zuvor gewährte Restricted Stock Units und Performance Stock Units repräsentiert sind, welche zum Zielniveau gemeldet wurden und der Vesting-Bedingung unterliegen.

Der Bericht legt außerdem 13.449 Performance-Optionsscheine mit einem Ausübungspreis von $81,85 offen, die an eine Gewährung mit der Leistungsbedingung gebunden sind, dass die Stammaktie an 20 aufeinanderfolgenden Handelstagen bei oder über $100 schließen muss, bevor sie ausübbar werden. Das Formular wurde von einem Bevollmächtigten ausgeführt.

Positive
  • Insider purchased shares: acquisition of 19,230 common shares at a weighted average of $25.49–$25.50
  • Significant ownership retained: reported direct beneficial ownership increased to 845,275 shares
  • Long-term alignment: ownership includes 591,998 RSUs/PSUs (reported at target), linking compensation to future performance
Negative
  • None.

Insights

TL;DR: CEO purchased 19,230 shares at ~$25.50, raising direct holdings to 845,275; transaction is modest in size relative to total holdings.

The reported purchase increases direct share holdings and confirms ongoing insider ownership. The disclosed 591,998 RSUs/PSUs (reported at target) comprise a substantial portion of total reported holdings, while the 13,449 performance options carry a high strike of $81.85 and a $100 performance hurdle. Taken together, the transactions and awards show continued executive equity exposure but do not, by themselves, represent a material capital event for the company.

TL;DR: Filing documents a routine insider purchase and long‑dated performance option subject to vesting and a price-based vesting condition.

The Form 4 discloses acquisition details and the makeup of beneficial ownership, including restricted and performance awards recorded at target levels. The performance option's exercisability is contingent on a sustained $100 share price condition, which is a clear contractual vesting metric. The form was signed by an attorney‑in‑fact, which is consistent with standard filing practice when the reporting person uses a designated agent.

Sarah London, direttore e amministratore delegato di Centene Corporation ha dichiarato un acquisto in mercato aperto di azioni ordinarie il 08/08/2025. Il deposito mostra l'acquisizione di 19.230 azioni a un prezzo medio ponderato di $25,49–$25,50, portando la sua partecipazione diretta dichiarata a 845.275 azioni. Il totale di proprietà include esplicitamente 591.998 azioni rappresentate da unità azionarie vincolate (RSU) e unità azionarie a prestazione (PSU) precedentemente assegnate, riportate al livello target e soggette a vesting.

La segnalazione rivela inoltre 13.449 opzioni azionarie di tipo performance con prezzo di esercizio di $81,85, legate a una concessione con condizione di performance secondo cui le azioni ordinarie devono chiudere a o sopra $100 per 20 giorni di negoziazione consecutivi prima che possano diventare esercitabili. Il modulo è stato firmato da un procuratore.

Sarah London, directora y consejera delegada de Centene Corporation, informó una compra en mercado abierto de acciones ordinarias el 08/08/2025. La presentación muestra la adquisición de 19.230 acciones a un precio medio ponderado de $25,49–$25,50, aumentando su propiedad directa declarada a 845.275 acciones. El total de propiedad incluye explícitamente 591.998 acciones representadas por unidades restringidas (RSU) y unidades de acciones por desempeño (PSU) previamente otorgadas, reportadas al nivel objetivo y sujetas a adquisición.

El informe también divulga 13.449 opciones de acciones de estilo rendimiento con un precio de ejercicio de $81,85, vinculadas a una concesión con la condición de rendimiento de que las acciones ordinarias cierren en o por encima de $100 durante 20 días de negociación consecutivos antes de que puedan hacerse ejercitables. El formulario fue firmado por un apoderado.

Centene Corporation 이사 겸 최고경영자(CEO) Sarah London은 2025년 8월 8일 공개 시장에서 보통주를 매수했다고 보고했습니다. 신고서에 따르면 가중평균 가격 $25.49–$25.5019,230주를 취득해 그녀의 신고된 직접 실질 보유주식이 845,275주로 증가했습니다. 소유 총액에는 이전에 부여된 제한부주식단위(RSU) 및 성과기반주식단위(PSU)로 보고된, 베스팅 대상의 591,998주가 명시적으로 포함되어 있습니다.

보고서에는 또한 행사 가격이 $81.8513,449개의 성과형 스톡옵션이 공개되어 있는데, 이는 보통주가 연속 20거래일 동안 $100 이상으로 종가를 기록해야만 행사 가능해지는 성과 조건이 붙은 부여와 연계되어 있습니다. 서식은 위임대리인이 서명했습니다.

Sarah London, administratrice et directrice générale de Centene Corporation, a déclaré un achat en marché ouvert d'actions ordinaires le 08/08/2025. Le dépôt indique l'acquisition de 19 230 actions à un prix moyen pondéré de 25,49 $–25,50 $, portant sa participation directe déclarée à 845 275 actions. Le total de propriété inclut explicitement 591 998 actions représentées par des unités d'actions restreintes (RSU) et des unités d'actions à performance (PSU) précédemment attribuées, déclarées au niveau cible et soumises au vesting.

Le rapport divulgue également 13 449 options d'actions de type performance avec un prix d'exercice de 81,85 $, liées à une attribution soumise à la condition de performance selon laquelle les actions ordinaires doivent clôturer à ou au-dessus de 100 $ pendant 20 jours de négociation consécutifs avant de pouvoir être exerçables. Le formulaire a été signé par un mandataire.

Sarah London, Direktorin und Chief Executive Officer von Centene Corporation, meldete am 08.08.2025 einen Kauf von Stammaktien am freien Markt. Die Meldung weist den Erwerb von 19.230 Aktien zu einem gewichteten Durchschnittspreis von $25,49–$25,50 aus und erhöhte ihr gemeldetes direktes wirtschaftliches Eigentum auf 845.275 Aktien. Die Gesamtbeteiligung schließt ausdrücklich 591.998 Aktien ein, die durch zuvor gewährte Restricted Stock Units und Performance Stock Units repräsentiert sind, welche zum Zielniveau gemeldet wurden und der Vesting-Bedingung unterliegen.

Der Bericht legt außerdem 13.449 Performance-Optionsscheine mit einem Ausübungspreis von $81,85 offen, die an eine Gewährung mit der Leistungsbedingung gebunden sind, dass die Stammaktie an 20 aufeinanderfolgenden Handelstagen bei oder über $100 schließen muss, bevor sie ausübbar werden. Das Formular wurde von einem Bevollmächtigten ausgeführt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LONDON SARAH

(Last) (First) (Middle)
7700 FORSYTH BOULEVARD

(Street)
ST. LOUIS MO 63105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CENTENE CORP [ CNC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 P 19,230 A $25.5(1) 845,275(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Option (right to buy) $81.85 (3) 12/15/2031 Common Stock 13,449 13,449 D
Explanation of Responses:
1. The weighted average price for this transaction is reported within the form. Shares were purchased at prices ranging from $25.49 to $25.50. Full information regarding the number of shares at each price is available upon request.
2. Ownership includes 591,998 shares of previously-granted restricted stock units and performance stock units (reported at target level performance) subject to vesting requirements.
3. Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date.
Remarks:
/s/ Christopher A. Koster (executed by attorney-in-fact) 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

When did Sarah London transact and how many shares did she buy (CNC)?

The Form 4 reports a purchase on 08/08/2025 of 19,230 common shares.

At what price were the CNC shares purchased by the reporting person?

The weighted average purchase price is reported as $25.49–$25.50.

How many Centene (CNC) shares does Sarah London beneficially own after the reported transaction?

Following the transaction, reported direct beneficial ownership is 845,275 shares.

What derivative securities does the filing disclose for Sarah London?

The filing discloses 13,449 performance-style stock options with an exercise price of $81.85 and an exercisability/expiration reference of 12/15/2031.

Does the reported ownership include restricted or performance stock units for CNC?

Yes. The filing states ownership includes 591,998 shares of previously-granted restricted stock units and performance stock units reported at target and subject to vesting.

Who executed the Form 4 filing for the reporting person?

The Form 4 shows execution by Christopher A. Koster acting as attorney-in-fact for the reporting person.
Centene Corp Del

NYSE:CNC

CNC Rankings

CNC Latest News

CNC Latest SEC Filings

CNC Stock Data

12.40B
488.80M
0.46%
101.12%
2.74%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ST LOUIS